NFKB1 and breast carcinoma: Use of sufentanil attenuated the invasiveness of breast cancer MDA-MB-231 cells via inhibition of NF-κB and NF-κB inhibitor α (IKBα) phosphorylation without changing levels of these factors [59] (Table 2).